BMS 140 857 Pill - white round, 11mm
Generic Name: dasatinib
Pill with imprint BMS 140 857 is White, Round and has been identified as Sprycel 140 mg. It is supplied by Bristol-Myers Squibb.
Sprycel is used in the treatment of Chronic Myelogenous Leukemia; Acute Lymphoblastic Leukemia; Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Sprycel 140 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 140 857
Sprycel
- Generic Name
- dasatinib
- Imprint
- BMS 140 857
- Strength
- 140 mg
- Color
- White
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Bristol-Myers Squibb
- National Drug Code (NDC)
- 00003-0857
- Inactive Ingredients
-
lactose monohydrate,
microcrystalline cellulose,
croscarmellose sodium,
magnesium stearate,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "BMS 140 857"
More about Sprycel (dasatinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (21)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.